文献速递白血病

糖皮质激素应答的表观基因组分析揭示影响儿童急性淋巴细胞白血病类固醇耐药的顺式调控破坏

Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2022-08-26

该研究利用功能基因组学和高通量报告基因试验,在两种急性淋巴细胞白血病(ALL)细胞系中绘制糖皮质激素(GC)的基因调控应答图谱,识别了数千个GC应答的染色质状态变化,包括250余个GC应答超级增强器形成及AP-1结合顺式调控元件耗竭;整合原代ALL细胞的遗传与表观遗传数据集,揭示GC应答基因的顺式调控破坏影响儿童ALL的GC耐药。

要点

  • 在两种ALL细胞系中绘制GC应答图谱,发现250余个GC应答超级增强器形成。
  • GC应答伴随AP-1结合顺式调控元件耗竭,涉及细胞增殖与抗凋亡过程。
  • 整合原代ALL细胞数据集,发现GC应答基因的顺式调控破坏影响GC耐药。

核心结论

  • GC对白血病表观基因组产生广泛影响,GC基因调控网络的改变参与GC耐药。

研究设计与样本

  • 利用功能基因组学和高通量报告基因试验,在两种ALL细胞系中绘制GC基因调控应答图谱。
  • 整合原代ALL细胞的遗传与表观遗传数据集进行分析。

主要发现

  • 在两种ALL细胞系中识别了数千个GC应答的染色质状态变化。
  • 发现超过250个GC应答超级增强器形成。
  • 发现AP-1结合顺式调控元件耗竭,这些元件涉及细胞增殖和抗凋亡过程。
  • 在原代ALL细胞中揭示GC应答基因的顺式调控破坏影响GC耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glucocorticoids (GCs) are a mainstay of contemporary, multidrug chemotherapy in the treatment of childhood acute lymphoblastic leukemia (ALL), and resistance to GCs remains a major clinical concern. Resistance to GCs is predictive of ALL relapse and poor clinical outcome, and therefore represents a major hurdle limiting further improvements in survival rates. While advances have been made in identifying genes implicated in GC resistance, there remains an insufficient understanding of the impact of cis-regulatory disruptions in resistance. To address this, we mapped the gene regulatory response to GCs in two ALL cell lines using functional genomics and high-throughput reporter assays and identified thousands of GC-responsive changes to chromatin state, including the formation of over 250 GC-responsive super-enhancers and a depletion of AP-1 bound cis-regulatory elements implicated in cell proliferation and anti-apoptotic processes. By integrating our GC response maps with genetic and epigenetic datasets in primary ALL cells from patients, we further uncovered cis-regulatory disruptions at GC-responsive genes that impact GC resistance in childhood ALL. Overall, these data indicate that GCs initiate pervasive effects on the leukemia epigenome, and that alterations to the GC gene regulatory network contribute to GC resistance.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Bergeron BP, Diedrich JD, Zhang Y, et al. Epigenomic profiling of glucocorticoid responses identifies cis-regulatory disruptions impacting steroid resistance in childhood acute lymphoblastic leukemia. Leukemia. 2022. PMID: 36028659. doi:10.1038/s41375-022-01685-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。